CS-1103 clinical trials
Also written CS-1103.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2024
How each study uses CS-1103 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- CS-1103
- 3
Studies by the year they started
3 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2026 | 2 |
Who runs them
Industry 3 · Other 0
Clear Scientific, Inc. (3)
Studies
Open first, then newest update. How each study uses CS-1103 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of MethamphetamineCompletedPhase 2Clear Scientific, Inc.NCT06721494Written as CS-1103
- A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone BlockadeCompletedPhase 2Clear Scientific, Inc.NCT07459166Written as CS-1103
- A Clinical Study to Evaluate the Safety of CS-1103 in Healthy ParticipantsCompletedPhase 1Clear Scientific, Inc.NCT06316973Written as CS-1103